within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01X_OtherAntibacterials.J01XX08_Linezolid;

model Linezolid_1
  extends Pharmacolibrary.Drugs.ATC.J.J01XX08_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01XX08_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Linezolid is a synthetic antibiotic of the oxazolidinone class. It is primarily used to treat infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Linezolid is approved for clinical use and commonly prescribed for pneumonia, skin and soft tissue infections, and other severe bacterial infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers aged 18-55 years after single IV 600 mg dose, both sexes.</p><h4>References</h4><ol><li><p>Heidari, S, &amp; Khalili, H (2023). Linezolid pharmacokinetics: a systematic review for the best clinical practice. <i>European journal of clinical pharmacology</i> 79(2) 195–206. DOI:<a href=\"https://doi.org/10.1007/s00228-022-03446-4\">10.1007/s00228-022-03446-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36565357/\">https://pubmed.ncbi.nlm.nih.gov/36565357</a></p></li><li><p>Thibault, C, et al., &amp; Autmizguine, J (2019). Population Pharmacokinetics of Intravenous Linezolid in Premature Infants. <i>The Pediatric infectious disease journal</i> 38(1) 82–88. DOI:<a href=\"https://doi.org/10.1097/INF.0000000000002067\">10.1097/INF.0000000000002067</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29634620/\">https://pubmed.ncbi.nlm.nih.gov/29634620</a></p></li><li><p>Sicard, M, et al., &amp; Guen, CG (2015). Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants. <i>European journal of clinical pharmacology</i> 71(5) 611–615. DOI:<a href=\"https://doi.org/10.1007/s00228-015-1813-3\">10.1007/s00228-015-1813-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25740677/\">https://pubmed.ncbi.nlm.nih.gov/25740677</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Linezolid_1;
